Ownership history in True Wealth Design, LLC · 3 quarters on record
This page tracks every 13F SEC filing in which True Wealth Design, LLC reported a position in MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 5 | — | 0% | 0.00% | $36 | $7.17 |
| 2025 Q2 | ADDED | 5 | +1 | +25.0% | 0.00% | $236 | $47.20 |
| 2025 Q1 | INITIATED | 4 | — | — | 0.00% | $157 | $39.07 |
As of 2025 Q4 — sorted by position size